Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-218767
Filing Date
2018-07-16
Accepted
2018-07-16 16:18:01
Documents
3
Period of Report
2018-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d526434d6k.htm 6-K 10676
2 EXHIBIT 99.1 d526434dex991.htm EX-99.1 14085
3 GRAPHIC g526434g0716073924700.jpg GRAPHIC 3160
  Complete submission text file 0001193125-18-218767.txt   30396
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0114
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 18954627
SIC: 2834 Pharmaceutical Preparations